Market Research Logo

US Market Report for Optical Biometry 2017 - MedCore

US Market Report for Optical Biometry 2017 - MedCore

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
The optical biometry device market is expected to grow over the forecast period due to sustained expansion of the number of units sold. Optical biometry devices are newer than ultrasound A-scans and pachymeters and are used in the same settings as these more traditional devices. In cataract surgery offices, optical biometry tends to be used alongside ultrasound equipment. The relatively new technology has not replaced the market for ultrasound devices because there remains a subset of cases for which ultrasound is a more effective measurement technique. As such, the market for optical biometry devices is driven more by the expansion of new and existing cataract surgery practices and less by the replacement of ultrasound devices with the more accurate alternative

With growth in the number of cataract procedures resulting from the aging population, practices are expected to continue to expand their capacity over the forecast period. In addition, new offices are expected to open at a rate similar to the growth of the patient pool. Prices, however, have established consistent values and will only see slight erosion throughout the forecast due to competition.

Optical biometers are partial coherence interferometry devices designed to generate a range of biometry measurements as well as to assist with intraocular lens (IOL) calculations. Optical biometers are capable of taking multiple measurements including axial length, anterior chamber depth, corneal thickness and lens thickness. All measurements are taken at a single optometry or ophthalmology station. Contact with the cornea is not required for the functioning of optical biometers, which improves measurement accuracy.


EXECUTIVE SUMMARY
U.S. DIAGNOSTIC OPHTHALMIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1.1 Glaucoma
2.1.2 Diabetic Retinopathy
2.1.3 Refractive Error
2.1.4 Age-Related Macular Degeneration
2.1.5 Astigmatism
2.1.6 Cataract
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Optical Biometry
3.2 FDA RECALLS
3.2.1 Alcon
3.2.2 Abbott Medical Optics (AMO)
3.2.3 Topcon
3.2.4 Nidek
3.3 CLINICAL TRIALS
3.3.1 Alcon
3.3.2 Carl Zeiss Meditec
3.3.3 Topcon
OPTICAL BIOMETRY MARKET
4.1 INTRODUCTION
4.2 MARKET ANALYSIS AND FORECAST
4.3 DRIVERS AND LIMITERS
4.3.1 Market Drivers
4.3.2 Market Limiters
4.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Diagnostic Ophthalmic Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Diagnostic Ophthalmic Device Market Overview, U.S., 2013 & 2023
Chart 4 1: Optical Biometry Market, U.S., 2013 – 2023
Chart 4 2: Leading Competitors, Optical Biometry Market, U.S., 2016
List of Figures
Figure 1 1: Diagnostic Ophthalmic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Diagnostic Ophthalmic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Diagnostic Ophthalmic Device Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Diagnostic Ophthalmic Device Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Diagnsotic Ophthalmic Device Market, U.S., 2013 – 2016 (1 of 2)
Figure 1 7: Recent Events in the Diagnsotic Ophthalmic Device Market, U.S., 2013 – 2016 (2 of 2)
Figure 1 8: Diagnostic Ophthalmic Device Markets Covered, U.S., 2016 (1 of 2)
Figure 1 9: Diagnostic Ophthalmic Device Markets Covered, U.S., 2016 (2 of 2)
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 3 1: Optical Biometry Devices by Company
Figure 3 2: Class 2 Device Recall Alcon
Figure 3 3: Class 2 Device Recall Alcon
Figure 3 4: Class 2 Device Recall Alcon
Figure 3 5: Class 2 Device Recall Alcon
Figure 3 6: Class 2 Device Recall Alcon
Figure 3 7: Class 2 Device Recall Alcon
Figure 3 8: Class 2 Device Recall Alcon
Figure 3 9: Class 2 Device Recall Alcon
Figure 3 10: Class 2 Device Recall Abbott Medical Optics
Figure 3 11: Class 2 Device Recall Abbott Medical Optics
Figure 3 12: Class 2 Device Recall Abbott Medical Optics
Figure 3 13: Class 2 Device Recall Abbott Medical Optics
Figure 3 14: Class 2 Device Recall Abbott Medical Optics
Figure 3 15: Class 2 Device Recall Abbott Medical Optics
Figure 3 16: Class 2 Device Recall Abbott Medical Optics
Figure 3 17: Class 2 Device Recall Abbott Medical Optics
Figure 3 18: Class 2 Device Recall Abbott Medical Optics
Figure 3 19: Class 2 Device Recall Abbott Medical Optics
Figure 3 20: Class 2 Device Recall Topcon
Figure 3 21: Class 2 Device Recall Nidek
Figure 3 22: Class 2 Device Recall Nidek
Figure 3 23: Clinical Investigation of Corneal Incision Size After Intraocular Lens (IOL) Implantation
Figure 3 24: Clinical Outcomes Following Treatment With SYSTANE® BALANCE
Figure 3 25: Clinical Evaluation of DAILIES TOTAL 1® Performance in a Japanese Population
Figure 3 26: CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers
Figure 3 27: Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal
Figure 3 28: Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Figure 3 29: Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions
Figure 3 30: Glaucoma HFA / OCT Specificity Study
Figure 3 31: OCT Image Quality Performance Evaluation
Figure 3 32: Evaluation of the Signal to Noise Ratio at Various Retinal Layers
Figure 3 33: Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment
Figure 4 1: Optical Biometry Market, U.S., 2013 – 2023
Figure 4 2: Drivers and Limiters, Optical Biometry Market, U.S., 2016
Figure 4 3: Leading Competitors, Optical Biometry Market, U.S., 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report